AU2005271944B2 - Preprimitive streak and mesendoderm cells - Google Patents

Preprimitive streak and mesendoderm cells Download PDF

Info

Publication number
AU2005271944B2
AU2005271944B2 AU2005271944A AU2005271944A AU2005271944B2 AU 2005271944 B2 AU2005271944 B2 AU 2005271944B2 AU 2005271944 A AU2005271944 A AU 2005271944A AU 2005271944 A AU2005271944 A AU 2005271944A AU 2005271944 B2 AU2005271944 B2 AU 2005271944B2
Authority
AU
Australia
Prior art keywords
cells
cell
expression
human
mesendoderm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005271944A
Other languages
English (en)
Other versions
AU2005271944A1 (en
Inventor
Alan D. Agulnick
Emmanuel E. Baetge
Kevin Allen D'amour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viacyte Inc
Original Assignee
Viacyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/021,618 external-priority patent/US7510876B2/en
Application filed by Viacyte Inc filed Critical Viacyte Inc
Publication of AU2005271944A1 publication Critical patent/AU2005271944A1/en
Assigned to VIACYTE, INC. reassignment VIACYTE, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CYTHERA, INC.
Application granted granted Critical
Publication of AU2005271944B2 publication Critical patent/AU2005271944B2/en
Priority to AU2012202529A priority Critical patent/AU2012202529B2/en
Priority to AU2015203517A priority patent/AU2015203517B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AU2005271944A 2004-07-09 2005-07-08 Preprimitive streak and mesendoderm cells Expired AU2005271944B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2012202529A AU2012202529B2 (en) 2004-07-09 2012-05-01 Preprimitive streak and mesendoderm cells
AU2015203517A AU2015203517B2 (en) 2004-07-09 2015-06-25 Preprimitive streak and mesendoderm cells

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US58656604P 2004-07-09 2004-07-09
US60/586,566 2004-07-09
US58794204P 2004-07-14 2004-07-14
US60/587,942 2004-07-14
US11/021,618 2004-12-23
US11/021,618 US7510876B2 (en) 2003-12-23 2004-12-23 Definitive endoderm
US69336405P 2005-06-23 2005-06-23
US60/693,364 2005-06-23
PCT/US2005/024161 WO2006017134A2 (en) 2004-07-09 2005-07-08 Preprimitive streak and mesendoderm cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012202529A Division AU2012202529B2 (en) 2004-07-09 2012-05-01 Preprimitive streak and mesendoderm cells

Publications (2)

Publication Number Publication Date
AU2005271944A1 AU2005271944A1 (en) 2006-02-16
AU2005271944B2 true AU2005271944B2 (en) 2012-02-16

Family

ID=40262947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005271944A Expired AU2005271944B2 (en) 2004-07-09 2005-07-08 Preprimitive streak and mesendoderm cells

Country Status (10)

Country Link
EP (2) EP1773986B1 (OSRAM)
JP (7) JP5433879B2 (OSRAM)
CN (1) CN102586170B (OSRAM)
AU (1) AU2005271944B2 (OSRAM)
CA (1) CA2573354C (OSRAM)
DK (2) DK2341147T3 (OSRAM)
ES (2) ES2754038T3 (OSRAM)
MX (1) MX2007000317A (OSRAM)
NZ (1) NZ582597A (OSRAM)
WO (1) WO2006017134A2 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
CN103898045B (zh) 2003-12-23 2019-02-01 维亚希特公司 定形内胚层
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
US7541185B2 (en) 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
WO2007059007A2 (en) 2005-11-14 2007-05-24 Cythera, Inc. Markers of definitive endoderm
US8187878B2 (en) 2004-08-13 2012-05-29 University Of Georgia Research Foundation, Inc. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
WO2006071911A2 (en) * 2004-12-23 2006-07-06 Cythera, Inc. Expansion of definitive endoderm cells
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
EP3584311A1 (en) 2005-10-27 2019-12-25 Viacyte, Inc. Pdx-1 expressing dorsal and ventral foregut endoderm
DK2420565T3 (en) 2006-02-23 2017-12-04 Viacyte Inc APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS
US11254916B2 (en) 2006-03-02 2022-02-22 Viacyte, Inc. Methods of making and using PDX1-positive pancreatic endoderm cells
EP2650359B1 (en) 2006-03-02 2022-05-04 Viacyte, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
WO2008013664A2 (en) 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
WO2008048647A1 (en) * 2006-10-17 2008-04-24 Cythera, Inc. Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells
US7695963B2 (en) 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
CN105349517B (zh) 2008-11-14 2021-05-04 维赛特公司 源于人多能干细胞的胰腺细胞的包封
CA2745742A1 (en) 2008-12-03 2010-06-10 International Stem Cell Corporation Methods of deriving differentiated cells from stem cells
AU2020283056B2 (en) 2019-05-31 2023-06-08 Viacyte, Inc. A biocompatible membrane composite
EP3976237A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP3976236A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. A biocompatible membrane composite
WO2020243666A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
WO2022040035A1 (en) 2020-08-15 2022-02-24 Regeneron Pharmaceuticals, Inc. Treatment of obesity in subjects having variant nucleic acid molecules encoding calcitonin receptor (calcr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050249A2 (en) * 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
WO2004098490A2 (en) * 2002-05-17 2004-11-18 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2161804A (en) 1935-11-09 1939-06-13 Baldwin Southwark Corp Hydraulic press
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2247502A1 (en) 1996-02-28 1997-09-04 Vanderbilt University Compositions and methods of making embryonic stem cells
WO1998030576A1 (en) * 1996-10-07 1998-07-16 The Johns Hopkins University School Of Medicine Novel hedgehog-derived polypeptides
AU736328B2 (en) * 1997-02-19 2001-07-26 Regeneron Pharmaceuticals, Inc. Morphogenic proteins
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6075007A (en) * 1997-07-17 2000-06-13 Regeneron Pharmaceuticals, Inc. Modified noggin polypeptide and compositions
JP3880795B2 (ja) 1997-10-23 2007-02-14 ジェロン・コーポレーション フィーダー細胞を含まない培養物中で、霊長類由来始原幹細胞を増殖させるための方法
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
JP2000217571A (ja) * 1999-01-29 2000-08-08 Japan Science & Technology Corp インビトロで誘導した移植用臓器
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7045353B2 (en) * 2000-08-01 2006-05-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Directed differentiation of human embryonic cells
AU2002360424A1 (en) * 2001-11-26 2003-06-10 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
WO2003089619A2 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
CN103898045B (zh) * 2003-12-23 2019-02-01 维亚希特公司 定形内胚层
US8187878B2 (en) * 2004-08-13 2012-05-29 University Of Georgia Research Foundation, Inc. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
US11586805B2 (en) 2021-07-26 2023-02-21 Atlassian Pty Ltd. Machine-learning-based natural language processing techniques for low-latency document summarization

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050249A2 (en) * 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
WO2004098490A2 (en) * 2002-05-17 2004-11-18 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kubo et al, Development (2004) vol 131, pps 1651-1662 *

Also Published As

Publication number Publication date
NZ582597A (en) 2011-08-26
DK1773986T3 (en) 2019-04-08
CN102586170B (zh) 2019-11-29
JP2008505643A (ja) 2008-02-28
JP5956388B2 (ja) 2016-07-27
JP7525102B2 (ja) 2024-07-30
CA2573354C (en) 2015-02-24
JP6077044B2 (ja) 2017-02-08
JP2022142795A (ja) 2022-09-30
JP6473708B2 (ja) 2019-02-20
JP2020103321A (ja) 2020-07-09
JP2016119919A (ja) 2016-07-07
JP6777620B2 (ja) 2020-10-28
EP1773986A2 (en) 2007-04-18
AU2005271944A1 (en) 2006-02-16
EP3505622A1 (en) 2019-07-03
JP2015130889A (ja) 2015-07-23
JP5433879B2 (ja) 2014-03-05
MX2007000317A (es) 2007-03-26
ES2716827T3 (es) 2019-06-17
WO2006017134A2 (en) 2006-02-16
WO2006017134A3 (en) 2007-01-18
EP1773986B1 (en) 2019-01-16
ES2754038T3 (es) 2020-04-15
CA2573354A1 (en) 2006-02-16
JP7161665B2 (ja) 2022-10-27
DK2341147T3 (da) 2019-11-11
JP2018027099A (ja) 2018-02-22
CN102586170A (zh) 2012-07-18
JP2013212121A (ja) 2013-10-17

Similar Documents

Publication Publication Date Title
US11667889B2 (en) Methods of making human primitive ectoderm cells
AU2005271944B2 (en) Preprimitive streak and mesendoderm cells
AU2005272078B2 (en) Methods for identifying factors for differentiating definitive endoderm
US8216836B2 (en) Methods for identifying factors for differentiating definitive endoderm
EP2341147B1 (en) Preprimitive streak and mesendoderm cells
CN101014702A (zh) 前原条和中内胚层细胞
AU2015203517B2 (en) Preprimitive streak and mesendoderm cells
AU2012202529B2 (en) Preprimitive streak and mesendoderm cells
AU2016235001B2 (en) Methods for identifying factors for differentiating definitive endoderm
HK1159689A (en) Preprimitive streak and mesendoderm cells
AU2013205842B2 (en) Methods for identifying factors for differentiating definitive endoderm

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: GERON CORPORATION

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND INVENTOR TO READ: D'AMOUR, KEVIN ALLEN; AGULNICK, ALAN D. AND BAETGE, EMMANUEL, E. .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ D'AMOUR, KEVIN ALLEN; AGULNICK, ALAN D. AND BAETGE, EMMANUEL, E.

CH Opposition withdrawn

Opponent name: GERON CORPORATION

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired